Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7301794 | 0.79 | NPC1 (0.46) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL209522 | 0.79 | RAB9A (0.54) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL7223282 | 0.79 | NPC1 (0.47) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL352664 | 0.78 | NPC1 (0.50) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL15286968 | 0.77 | NPC1 (0.54) | NPC1RAB9ANOTUMTP53TSHR | |
| SCHEMBL8625869 | 0.77 | CASP3 (0.40) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL1550945 | 0.77 | PKM (0.52) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL2360245 | 0.75 | NPC1 (0.50) | NPC1RAB9AKDM4ENOTUMTP53 | |
| SCHEMBL5945926 | 0.75 | NPC1 (0.44) | NPC1RAB9AKDM4EHSD17B10NOTUM | |
| SCHEMBL11219018 | 0.75 | NOTUM (0.53) | NPC1NOTUMMAOAMAOBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103209979-A | Therapeutic agent 976 | ASTRAZENECA AB | 2013-07-17 | — | — | CN | claimed |
| CN-102256983-A | Spirooxindole compounds and their use as therapeutic agents | XENON PHARMACEUTICALS INC | 2011-11-23 | — | — | CN | claimed |
| CN-101415713-A | New spiro [imidazolidine-4, 3'-indole]-2,2',5 (1'H)-trione useful for the treatment of vanilloid receptor 1-related disorders | ASTRAZENECA AB (SE) | 2009-04-22 | — | — | CN | claimed |
| US-20230174533-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-06-08 | — | — | US | disclosed |
| US-11555037-B2 | Purine diones as Wnt pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-01-17 | — | — | US | disclosed |
| CN-114980894-A | Modulators of integrated stress response pathways | 埃沃特克国际有限责任公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-109776537-B | Purine diones as WNT pathway modulators | 新加坡科技研究局 | 2021-12-14 | — | — | CN | disclosed |
| CN-110846675-B | Synthetic method of 2- (5-aryl-1, 3, 4-oxadiazole-2-yl) aniline compound | 阜阳师范大学 | 2021-05-28 | — | — | CN | disclosed |
| US-20210155623-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-05-27 | — | — | US | disclosed |
| US-10844063-B2 | Purine diones as Wnt pathway modulators | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-11-24 | — | — | US | disclosed |
| US-20200190086-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2020-06-18 | — | — | US | disclosed |
| US-4162254-A | Benzoxazole ultraviolet stabilizers | EASTMAN KODAK COMPANY (US) | 1979-07-24 | — | — | US | disclosed |
| US-4159985-A | Heterocyclic phenyl ester ultraviolet stabilizers | EASTMAN KODAK COMPANY (US) | 1979-07-03 | — | — | US | disclosed |
| US-4140674-A | FOR POLYMERS | EASTMAN KODAK COMPANY (US) | 1979-02-20 | — | — | US | disclosed |
| US-4137235-A | ULTRAVIOLET STABILIZERS IN POLYMERIC COMPOSITIONS | EASTMAN KODAK COMPANY (US) | 1979-01-30 | — | — | US | disclosed |
| US-4116928-A | Heterocylic ester, ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4116929-A | POLYESTERS | EASTMAN KODAK COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4096115-A | Ultraviolet light stabilized polymers | EASTMAN KODAK COMPANY (US) | 1978-06-20 | — | — | US | disclosed |
| US-4020080-A | Oxadiazolylphenyl aromatic ester compounds and their use as ultraviolet stabilizer in organic compositions | EASTMAN KODAK COMPANY (US) | 1977-04-26 | — | — | US | disclosed |
| US-4016159-A | BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11555037-B2 | Purine diones as Wnt pathway modulators | WNT1, WNT3A, WNT3 | NPC1 2768/4885RAB9A 3313/4885KDM4E 3291/4885 |
| US-20200190086-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | WNT1, WNT3A, CTNNB1 | NPC1 2489/4885RAB9A 3162/4885KDM4E 3779/4885 |
| US-20230174533-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | WNT1, WNT3A, WNT3 | NPC1 2768/4885RAB9A 3313/4885KDM4E 3291/4885 |
| US-10844063-B2 | Purine diones as Wnt pathway modulators | WNT1, WNT3A, CTNNB1 | NPC1 2489/4885RAB9A 3162/4885KDM4E 3779/4885 |
| US-20210155623-A1 | PURINE DIONES AS WNT PATHWAY MODULATORS | WNT1, WNT3A, WNT3 | NPC1 2768/4885RAB9A 3313/4885KDM4E 3291/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.